Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00541_DB00976> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00541_DB00976 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00541_DB00976 label "DDI between Vincristine and Telithromycin - Telithromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vincristine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Telithromycin is initiated, discontinued or dose changed. [drugbank_resource:DB00541_DB00976]" assertion.
- drugbank_resource:DB00541_DB00976 identifier "drugbank_resource:DB00541_DB00976" assertion.
- drugbank_resource:DB00541_DB00976 title "DDI between Vincristine and Telithromycin - Telithromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vincristine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Telithromycin is initiated, discontinued or dose changed." assertion.